Back to MW MARSHALL WACE, LLP
DFTX3 quarters
Position history for MWMARSHALL WACE, LLP's holdings in Definium Therapeutics, Inc.
MARSHALL WACE, LLP holds 1.3M shares of DFTX (Definium Therapeutics, Inc.), worth $61.1M as of 2026-Q2. The position was increased (+8.2% shares). DFTX represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$61.1M
Current Shares
1.3M
Total Value Change
+$21.3M
Total Shares Change
-1.7M
Quarter-by-Quarter History
Other major holders of DFTX: BlackRock, Inc., Avoro Capital Advisors LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, Capital World Investors, FMR LLC